Interní Med. 2007; 9(11): 525-528

Depression and its treatment in cardiovascular diseases

doc. MUDr. Vladimír Pidrman Ph.D
Psychiatrická klinika FN a LF UP, Olomouc

The author describes relations between prevalence of depression and cardiovascular diseases. A substantial part of the article is consecrated to a correct antidepressive treatment. Properties, advantages and eventual side-effects of individual groups of current antidepressive medications are described.

Keywords: depression, antidepressive medications, SSRI, SNRI, NDRI, NASA, cardiovascular diseases

Published: January 1, 2008  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Pidrman V. Depression and its treatment in cardiovascular diseases. Interní Med. 2007;9(11):525-528.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Alexopoulos GS, Katz IR, Reynolds CF, Carpenter D, Docherty JP. Pharmacotherapy of depressive disorders in older patients. Comprehensive NeuroScience Inc., New York, 2001, 76 s.
    2. Alves TC, Rays J, Telles RM et al. Effects of antidepressant treatment on cognitive performance in elderly subjects with heart failure and comorbid major depression: an exploratory study. Psychosomatics, 2007; 48 (1): 22-30. Go to original source... Go to PubMed...
    3. Aziz R, Lorberg B, Tampi RR. Treatments for late-life bipolar disorder. Am J Geriatr Pharmacother, 2006; 4 (4): 347-364. Go to original source... Go to PubMed...
    4. Barak Y, Olmer A, Aizenberg D. Antidepressants redukce the risk of suicide aminy elderly depressed patients. Neuropsychopharmacology, 2006; 31 (1): 178-181. Go to original source... Go to PubMed...
    5. Bazire S. Psychotropic drug directory 2005. Mark Alen Publishing Ltd., Jesses Farm, 2004, 340 s.
    6. Bednar MM, Harrigan EP, Anziano RJ, Camm AJ, Ruskin JN. The QT interval. Progress in cardiovaskular diseases, 2001; 43(5) (Suppl. 1): 1-45. Go to original source...
    7. Berger A, Dukes E, Edelsberg J, Stacey B, Oster G. Use of tricyclic antidepressants in older patients with diabetic peripheral neuropathy. Clin J Pain, 2007; 23 (3): 251-258. Go to original source... Go to PubMed...
    8. Brenes GA, Williamson JD, Messier SP et al. Treatment of minor depression in older adults: a pilot study comparing sertraline and exercise. Aging Ment Health, 2007; 11 (1): 61-68. Go to original source... Go to PubMed...
    9. Dew MA, Whyte EM, Lenze EJ, Houck PR et al. Recovery from major depression in older adults receiving augmentation of antidepressant pharmacotherapy. Am J Psychiatry, 2007; 164 (6): 892-899. Go to original source... Go to PubMed...
    10. Flint AJ, Rifat SL. Maintenance treatment for recurrent depression in late life: a four year outcome study. Am J Geriatr Psychiatry, 2000; 8 (2): 112-116. Go to original source...
    11. Goodyer JM. Unipolar depression. Oxford University Press, New York, 2003: 212 s.
    12. Henn F, Sartorius N, Helmchen H, Lauter H. Contemporary psychiatry. Springer, Berlin, 2001, 2258 s. Go to original source...
    13. Holmerová I, Jurašková B, Vaňková H, Veleta P. Křehkost vyššího věku a sarkopenie jako její důležitá komponenta. Čes ger rev 2007; 5 (1): 24-29.
    14. Holmerová I, Vaňková H, Jurašková B. Deprese ve stáří. In: Deprese z různých úhlů pohledu II. Praha, Galén, 2007; 93-123.
    15. Holmerová I, Vaňková H, Dragomirecká E, Janečková H, Veleta P. Depresivní syndrom u seniorů, významný a dosud nedoceněný problém. Psychiat. pro Praxi, 2006, 4: 182-184.
    16. Hunkeler EM, Katon W, Tang L, Williams JW Jr. et al. Long term outcomes from the IMPACT randomised trial for depressed elderly patients in primary care. BMJ, 2006; 332 (7536): 259-263. Go to original source... Go to PubMed...
    17. Grossberg GT, Stehelin HB, Mesina JC, Anand R, Veach J. Lack of adverse pharmacodynamic drug interactions with rivastigmine and twenty-two classes of mediacations. Int J Geriatr Psychiatry 2002; 15: 242-247. Go to original source...
    18. Jacobson SA, Preis RW, Greenblatt DJ. Handbook of geriatric psychopharmacology. American Psychiatric Publishing Inc., Washington DC, 2002, 445 s.
    19. Juurlink DN, Mandami MM, Kopp A, Redelmeier DA. The risk of suicide with selective serotonin reuptake inhibitors in the elderly. Am J Psychiatry, 2006 May; 163 (5): 813-21. Comment in: Am J Psychiatry, 2006; 163 (9): 1644; autor reply 1644-1645. Go to original source... Go to PubMed...
    20. Levy RH, Collins C. Risk and predictability of drug interactions in the elderly. Int Rev Neurobiol, 2007; 81: 235-251. Go to original source... Go to PubMed...
    21. Malzberg B. Mortality among patients with involuntional melancholia. Am J Psychiatry 1937, 93, 1231-1238. Go to original source...
    22. Mottram P, Wilson K, Strobl J. Antidepressants for depressed elderly. Cochrane Database Syst Rev. 2006; 25(1): CD003491. Go to original source... Go to PubMed...
    23. Pidrman V. Deprese a kardiovaskulární onemocnění. 3. rozšířené vydání, Maxdorf, Praha, 2004: 68 s.
    24. Pidrman V. Deprese seniorů. Praha, Maxdorf, 2003, s. 60.
    25. Pinquart M, Duberstein PR, Lyness JM. Treatments for later-life depressive conditions: a metaanalytic comparison of pharmacotherapy and psychotherapy. Am J Psychiatry, 2006; 163(9): 1493-1501. Go to original source... Go to PubMed...
    26. Reynolds CF 3rd, Dew MA, Pollock BG, Mulsant BH, Frank E. Maitenance treatment of major depression in old age. N Engl J Med, 2006; 354 (11): 1130-1138. Go to original source... Go to PubMed...
    27. Reuben BD, Herr KA, Pacala JT et al. Geriatrics. Blackwell Publishing Inc., Malden, 2003, 240 s.
    28. Sauer WH, Berlin JA, Kimmel SE. Selective serotonin reuptake inhibitors and myocardial infarction. Circulation, 104, 2001: 1894-1898. Go to original source... Go to PubMed...
    29. Shiloh R, Nutt D, Weizman A. Atlas of psychotropic pharmacotherapy. Martin Dunitz, London, 2000, 235 s.
    30. Schaltberg AF, Cole JO, DeBatista C. Manual of clinical psychopharmacology. American Psychiatric Publishing Inc. Washington DC, 2003, 700 s.
    31. Sneed JR, Roose SP, Keilp JG, Krishnan KR, Alexopoulos GS, Sackeim HA. Response inhibition predicts poor antidepressant treatment response in very old depressed patients. Am J Geriatr Psychiatry, 2007; 15 (7): 553-563. Go to original source... Go to PubMed...
    32. Solai LK, Mulsant BH, Pollock BG. Selective serotonin reuptake inhibitors for late-life depression: a comparative review. Drug Aging, 2001; 18 (5): 355-368. Go to original source... Go to PubMed...
    33. Stahl MS. Essential psychopharmacology. Neuroscientific basis and practical applications. Cambridge University Press, Cambridge, 2002, 602 s.
    34. Špinar J, Adámková R. Budeme umírat na infarkt myokardu i v 21. století? Interní Med. 2007; 9 (10): 4145.
    35. Thompson S, Herrmann N, Rapoport MJ, Lanctôt KL. Efficacy and safety of antidepressants for treatment of depression in Alzheimer´s disease: a metaanalysis. Can J Psychiatry, 2007; 52 (4): 248-255. Go to original source... Go to PubMed...
    36. Unűtzer J, Tang L, Oishi S et al. Reducing suicidal ideation in depressed older primary care patients. J A Geriatr Soc, 2006; 54 (10): 1550-1556. Go to original source... Go to PubMed...

    Return to the content


    Internal Medicine for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.